Filter trials by:

Year

Indication

Phase

Type

Year: 2012

Use of Duloxetine or Pregabalin in Monotherapy versus Combination Therapy of Both Drugs in Patients with Painful Diabetic Neuropathy “The COMBO – DN” (Combination vs Monotherapy of Pregabalin and duloxetine in Diabetic Neuropathy).
  • Year: 2012
  • Type: Pharmaceutical - Pain
  • Phase: IIIb
  • Indication: Painful Diabetic Neuropathy
A randomised, double-blind, double-dummy, parallel-group multicentre study to demonstrate improvement in symptoms of constipation and noninferiority in analgesic efficacy in subjects with non-malignant or malignant pain that requires around-the-clock opioid therapy taking 50/25 – 80/40 mg twice daily as oxycodone/naloxone prolonged release (OXN PR) tablets compared to subjects taking 50 – 80 mg twice daily oxycodone prolonged release (OxyPR) tablets alone.
  • Year: 2012
  • Type: Pharmaceutical - Pain
  • Phase: III
  • Indication: Pain - General
A Multi-Centre, Randomised, Double-Blinded, Placebo Controlled, Parallel Group, Multiple Dose Study of the Efficacy of 8.75mg Flurbiprofen Spray in the Relief of Sore Throat due to URTI.
  • Year: 2012
  • Type: Pharmaceutical - Other
  • Phase: III
  • Indication: Other
An Open-label Historically Controlled Study to Assess the Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects with Multiple Dupuytren’s Contractures with Palpable Cords.
  • Year: 2012
  • Type: Musculoskeletal
  • Phase: IIIb
  • Indication: Other
A Prospective Trial to Assess the Safety and Performance of the Spinal Modulation Neurostimulator System in the Treatment of Chronic Pain.
  • Year: 2012
  • Type: Device
  • Phase: N/A
  • Indication: Chronic Trunk and/or Limb Pain
Precision High-Rate Sub-perception Spinal Cord Stimulation for the Treatment of Chronic Intractable Pain.
  • Year: 2012
  • Type: Device
  • Phase: N/A
  • Indication: Back and/or Leg Pain
A Double Blind, Randomised, Parallel Group, Dose-Ranging Study Comparing FX006 to Commercially Available Triamcinolone Acetonide Injectable Suspension in Patients with Osteoarthritis of the Knee.
  • Year: 2012
  • Type: Musculoskeletal
  • Phase: II
  • Indication: Knee Osteoarthritis
Partnership for Advancement in Neuromodulation (PAIN): A Prospective Clinical Outcomes Registry.
  • Year: 2012
  • Type: Device
  • Phase: Post-Market
  • Indication: Chronic Trunk and/or Limb Pain

CONNECT WITH US

Facebook Linkedin Instagram Envelope Phone

CONTACT US

CovidSafe - Newcastle Research Institute - Genesis Research Services

Disclaimer: This website provides general information only; it should not be construed as medical advice nor does it replace the need to seek medical advice from a qualified medical professional. To the maximum extent permitted by law, Genesis Research Services Pty Ltd will not be liable in any way for any injury, loss or damage suffered by you through accessing or using the information on this website. View our Privacy Policy. You are strictly prohibited from downloading, copying, altering, modifying, distributing, adapting, modifying and/or re-transmitting any or all of the content on the website for any commercial use without the written consent of Genesis Research Services.